![]() |
|
|
Institute of Food Science and Nutrition, ETH Zurich, 8092 Zurich, Switzerland
* To whom correspondence should be addressed. E-mail: richard.hurrell{at}ilw.agrl.ethz.ch.
| ABSTRACT |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
GAG are part of the connective tissue between the muscle fibers and represent
0.1% of muscle wet weight (13). Seven different types of GAG have been described (Table 1), the differences being related to disaccharide subunit composition and degree of sulfation. Contributions of the subclasses to the total GAG content of muscle tissue vary, depending on factors like species, age, and tissue source (14,15). In mouse muscle tissue, hyaluronic acid (HA) accounted for
70% of the total GAG, whereas dermatan sulfate (chondroitin sulfate B), the major fraction among the sulfated GAG, contributed 20% (14). The remainder was made up by chondroitin sulfate (CS) and heparan sulfate. Likewise, chondroitin sulfate B was reported to be the major sulfated GAG in rabbit muscle (16) and porcine skeletal muscle epimysium (17), namely, 80–90% of total sulfated GAG. However, others reported chondroitin sulfate A/C (i.e., 4- or 6-sulfated CS) to constitute 44% of the total hexuronic acid content in rabbit muscle (18). HA consists of repeating disaccharide units of N-acetyl-glucosamine and D-glucuronic acid. CS differs from HA in that N-acetyl-glucosamine is replaced by N-acetyl-galactosamine and the C4 or C6 of the galactosamine is sulfated. Whereas HA is the only unsulfated GAG, CS can be viewed as representative of sulfated GAG.
|
| Subjects and Methods |
|---|
|
|
|---|
Exclusion criteria included pregnancy or lactation and known gastrointestinal or metabolic disorders. No medication (except oral contraceptives) or vitamin or mineral supplements were allowed during the study. Women regularly taking vitamin or mineral supplements discontinued supplementation 2 wk before the start and during the study. No subjects were recruited who had donated blood within 4 mo of the beginning of the study or who were planning to donate blood during the study period.
The study protocol was reviewed and approved by the Ethical Committees of ETH Zurich and of the canton of Zurich. Subjects were informed orally and in writing about the aims and procedures of the study. Written informed consent was obtained from all study subjects.
Study design. Iron absorption was determined with the use of a double stable-isotope technique and based on erythrocyte incorporation of 57Fe or 58Fe 14 d after test meal administration. Each subject received a total of 4 test meals (meal A twice, and meals B and C once each; see below). All test meals were consumed between 0700 and 0900, after the subjects had fasted overnight, under standardized conditions. Each subject acted as her own control and received the purified GAG in a fully randomized crossover design.
A few days prior to the first test meal administration (day 0), a baseline venous blood sample was drawn after an overnight fast to determine iron status (plasma ferritin, hemoglobin), and subjects' height and weight were recorded.
The subjects consumed the first 2 labeled test meals on 2 consecutive days (d 1 and 2). Fourteen days later (d 16), a second blood sample was drawn, followed by the administration of test meals 3 (d 17) and 4 (d 18). Another 14 d later (d 32), a final blood sample was drawn.
Test meals.
The control meal (meal A) was a semisynthetic meal (SSM) consisting of 67 g hydrolyzed corn starch (CStar MD 01910, Cargill Cerestar, Blattmann AG), 35 g corn oil (Mazola, Unilever), 35.2 g egg white (Monark Egg ) corresponding to 30 g protein and 200 mL high-purity (18 M
) water. Pineapple flavor (74185–33, Givaudan), which is devoid of carboxylic and phenolic groups likely to interact with iron, was added at 0.05% (v:w). SSM shakes were prepared freshly the day before consumption. The test meal (meal B) in study 1 consisted of the SSM, to which 300 mg food-grade sodium hyaluronate (Freda Biochem) was added on the morning of meal administration. In study 2 (meal C) the NaH was replaced by 360 mg food-grade chondroitin sulfate (CS, from shark cartilage, Paul Bruns GmbH).
The amount of NaH was estimated to equal 2 to 3 times the daily consumption with a meat intake of
150 g/d (13,24). For CS, the same amount on a molar basis, 360 mg, was added to allow for better comparison, although CS intake would most probably be closer to 20–30 mg/d. NaH had a molecular weight of 1000–1200 kDa and contained 97.03% hyaluronic acid according to the certificate of analysis. CS was of
20 kDa molecular weight and contained 92.3% chondroitin sulfate (10% C4-sulfated and 90% C6-sulfated), the remainder being protein (<6%), ash, and water. High-purity water (230 g) was served as a drink.
With each control and test meal, a separate high-purity water drink (70 g) containing 4 mg of iron, added as isotopically labeled ferrous sulfate (57FeSO4 or 58FeSO4) on the morning of consumption, was served. Subjects were asked to start with the SSM and to intermittently drink the water. No time restriction was imposed but all subjects finished their SSM within 5–25 min. Control and test meals were fed once per study. To alleviate any unpleasant aftertaste, the subjects received a peppermint-flavored Wrigley's Eclipse Flash strip after each meal.
Preparation and quantification of stable isotope labels in solutions and in blood. Preparation of the stable-isotope labels, quantification of iron in isotope solutions and in the blood, and calculation of iron absorption were performed as described previously (25).
Iron status measurements. Venous blood samples (7 mL) were drawn into EDTA-treated vacutainers (368453, Becton Dickinson) a few days before the first test meal administration and again 14 d after the first and second set of test meals on d 16 and d 32 of the study, respectively. Samples were analyzed for iron status indexes (plasma ferritin, hemoglobin; d 0) and for the incorporation of 57Fe and 58Fe into erythrocytes (d 16, d 32). Hemoglobin was measured in fresh whole blood using the cyanmethemoglobin method (D5941, Sigma). Plasma was separated and stored frozen for later ferritin analysis with the use of an enzymatic immunoassay (Immulite, DPC Bühlmann GmbH). Commercial quality control materials for hemoglobin (Digitana AG) and ferritin (Immulite) were run with each analysis.
Statistics. Student's paired t test was used to evaluate study data. Values were logarithmically transformed before statistical analysis (EXCEL 2002 SP3, Microsoft ). Results are presented as geometric means (±1 SD) and were considered statistically significant at P < 0.05. Post-hoc power calculations for paired t tests were performed using GraphPad StatMate for Windows, version 2.00 (GraphPad ) with n = 14 in study 1 and n = 15 in study 2. The same 14 subjects in study 1 and study 2 were used for paired comparison between the NaH-containing SSM and the CS-containing SSM after normalization for mean isotope absorption from the GAG-free reference SSM in both studies.
| Results |
|---|
|
|
|---|
Iron absorption.
The geometric mean absorption from the control meal was 19.5% in the NaH study and 20.3% in the CS study (Table 2). Iron absorption from the SSM containing GAG was 21.2% for NaH and 19.4% for CS. Absorption from test meals did not differ from control (NaH: P = 0.42; CS: P = 0.64). After normalization for mean iron absorption from the GAG-free SSM (20.5%) in the 14 subjects who participated in both studies, absorption from the GAG-containing meals did not differ (P = 0.50) The study design allowed detecting a change in iron absorption of
30% at 80% power.
|
| Discussion |
|---|
|
|
|---|
Data on meat consumption from the European Prospective Investigation into Cancer and Nutrition (EPIC) study showed that total meat intake ranged between 46–127 g/d in women and 79–242 g/d in men (24). Assuming that the total glycosaminoglycan content in meat of different species does not vary greatly, the estimated GAG intake would thus amount to 46–127 mg/d in women and 79–242 mg/d in men. Unfortunately, data on GAG composition in meat used for human consumption is scarce. In mouse muscle tissue, the unsulfated GAG hyaluronic acid (HA) constitutes
70% of total GAG (14), the remainder being sulfated GAG like chondroitin sulfate B (dermatan sulfate) or heparan sulfate. Thus, daily HA and sulfated GAG intakes probably range between 32–169 mg/d and 14–73 mg/d, respectively. The rationale for using 300 mg of NaH was to simulate an intake 2–3 times the daily consumption of nonvegetarians. To allow for direct comparison between NaH and CS, we fed the same molar amounts of CS (calculated on a disaccharide subunit basis), although dietary CS intake would be only about one-fifth of NaH intake. It is still possible but unlikely that it could be enhancing at lower levels.
Soluble HA-iron complexes form at a molar ratio of 3:1 (HA disaccharide:Fe) and iron interacts specifically with the acetylated nitrogen of N-acetyl-glucosamine in aqueous solution (21). In the present study, a GAG disaccharide:Fe molar ratio of
10:1 was employed. Molar ratio is a key issue in the study of enhancers and inhibitors of iron absorption. Usually, dietary factors influencing iron absorption show a more or less pronounced dose-response relation (26–29). The only known exception is EDTA, which, when added to meals of low bioavailability at a molar ratio of
1:1, acts as an enhancer (30,31), whereas higher EDTA:Fe ratios lead to decreased iron absorption (30). Thus, the lack of any effect at the rather high molar GAG:Fe ratio used in the present study makes it unlikely but not impossible that a lower molar GAG:Fe ratio would change dietary iron bioavailability. If larger amounts of GAG had a beneficial effect, however, they would have to be provided by dietary supplements.
During synthesis, GAG can undergo several chemical modifications such as (de-)sulfation, (de-)acetylation or epimerization. Huh et al. (7) report that preliminary characterization of their chicken and fish extracts suggested highly acidic oversulfated heparan sulfate moieties as major constituents of the fractions enhancing Caco-2 cell iron uptake and virtual absence of proteins, peptides, and amino acids. It is still possible that this small specific fraction of muscle GAG could be an iron absorption enhancer. However, it should be stressed that these Caco-2 studies were made by adding the acid-soluble fractions onto Caco-2 cells directly without the addition of a meal. When other positive or negative ligands are present from partially digested food, the influence of the acid extract could be very different.
The high cost of commercial heparan sulfate prevented its use in the present study. Large-scale production for human feeding trials of the fish extract used in the Caco-2 experiments was attempted but was unsuccessful. Whether the chemical modification of GAG substantially modulates their influence on iron bioavailability remains to be determined. Generally, differences among the different types of GAG largely relate to their sequence of disaccharide subunits so that fragments of low molecular weight become increasingly similar to one another. To what extent GAG are modified during digestion, i.e., gastric acid treatment as simulated by HCl incubation in the study by Huh et al. (7), is difficult to tell. However, gastric digestion in humans would probably release low-molecular-weight oligosaccharides from larger GAG molecules in a similar fashion to that observed in the Caco-2 study.
In conclusion, the purified glycosaminoglycans sodium hyaluronate and chondroitin sulfate had no detectable effect on iron absorption from a semisynthetic meal. The GAG doses administered represented intake levels achievable with very high meat consumption or low-dose supplement use. It is unlikely that these compounds constitute a major part of the meat factor. However, the potential role of chemical modifications to the GAG structure and the GAG:Fe molar ratio warrant further investigation.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
2 Author disclosures: S. Storcksdieck genannt Bonsmann, no conflicts of interest; T. Walczyk, no conflicts of interest; S. Renggli, no conflicts of interest; and R. F. Hurrell, no conflicts of interest. ![]()
3 Abbreviations used: CS, chondroitin sulfate; GAG, glycosaminoglycan(s); HA, hyaluronic acid; SSM, semisynthetic meal. ![]()
Manuscript received 14 December 2006. Initial review completed 29 January 2007. Revision accepted 19 February 2007.
| LITERATURE CITED |
|---|
|
|
|---|
1. Martinez-Torres C, Layrisse M. Iron absorption from veal muscle. Am J Clin Nutr. 1971;24:531–40.[Abstract]
2. Martinez-Torres C, Leets I, Layrisse M. Iron absorption by humans from fish. Arch Latinoam Nutr. 1975;25:199–210.[Medline]
3. Bjorn-Rasmussen E, Hallberg L. Effect of animal proteins on the absorption of food iron in man. Nutr Metab. 1979;23:192–202.[Medline]
4. Martinez-Torres C, Layrisse M. Effect of amino acids on iron absorption from a staple vegetable food. Blood. 1970;35:669–82.
5. Monsen ER, Cook JD. Food iron absorption in human subjects. V. Effects of the major dietary constituents of semisynthetic meal. Am J Clin Nutr. 1979;32:804–8.
6. Taylor PG, Martinez-Torres C, Romano EL, Layrisse M. The effect of cysteine-containing peptides released during meat digestion on iron absorption in humans. Am J Clin Nutr. 1986;43:68–71.
7. Huh EC, Hotchkiss A, Brouillette J, Glahn RP. Carbohydrate Fractions from cooked fish promote iron uptake by Caco-2 cells. J Nutr. 2004;134:1681–9.
8. Pinto M, Robine-Leon S, Appay MD, Kedinger M, Triadou N, Dussaulx E, Lacroix B, Simon-Assmann P, Haffen K, et al. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol Cell. 1983;47:323–30.
9. Garcia MN, Flowers C, Cook JD. The Caco-2 cell culture system can be used as a model to study food iron availability. J Nutr. 1996;126:251–8.
10. Au AP, Reddy MB. Caco-2 cells can be used to assess human iron bioavailability from a semipurified meal. J Nutr. 2000;130:1329–34.
11. Glahn RP, Wien EM, Van Campen DR, Miller DD. Caco-2 cell iron uptake from meat and casein digests parallels in vivo studies: use of a novel in vitro method for rapid estimation of iron bioavailability. J Nutr. 1996;126:332–9.
12. Yun S, Habicht J-P, Miller DD, Glahn RP. An in vitro digestion/Caco-2 cell culture system accurately predicts the effects of ascorbic acid and polyphenolic compounds on iron bioavailability in humans. J Nutr. 2004;134:2717–21.
13. Pedersen ME, Kolset SO, Sorensen T, Eggen KH. Sulfated glycosaminoglycans and collagen in two bovine muscles (M. Semitendinosus and M. Psoas major) differing in texture. J Agric Food Chem. 1999;47:1445–52.[Medline]
14. Watanabe K, Oohira A, Uramoto I, Totsuka T. Age-related changes in the content and composition of glycosaminoglycans isolated from the mouse skeletal muscle: normal and dystrophic conditions. J Biochem (Tokyo). 1986;100:167–73.
15. Dietrich CP, Sampaio LO, Toledo OM. Characteristic distribution of sulfated mucopolysaccharides in different tissues and in their respective mitochondria. Biochem Biophys Res Commun. 1976;71:1–10.[Medline]
16. Toledo OM, Dietrich CP. Tissue specific distribution of sulfated mucopolysaccharides in mammals. Biochim Biophys Acta. 1977;498:114–22.[Medline]
17. Nakano T, Sunwoo HH, Li XJ, Price MA, Sim JS. Study of sulfated glycosaminoglycans from porcine skeletal muscle epimysium including analysis of iduronosyl and glucuronosyl residues in galactosaminoglycan fractions. J Agric Food Chem. 1996;44:1424–34.
18. Parthasarathy N, Tanzer ML. Isolation and characterization of a low molecular weight chondroitin sulfate proteoglycan from rabbit skeletal muscle. Biochemistry. 1987;26:3149–56.[Medline]
19. Barone D, Orlando L, Vigna E, Baroni S, Borghi AM. Ferric chondroitin 6-sulfate (Condrofer): a new potent antianaemic agent with a favourable pharmacokinetic profile. Drugs Exp Clin Res. 1988;14: Suppl 1:1–14.
20. Allegra V, Mengozzi G, Vasile A. Iron deficiency in maintenance hemodialysis patients: assessment of diagnosis criteria and of three different iron treatments. Nephron. 1991;57:175–82.[Medline]
21. Merce ALR, Marques Carrera LC, Santos Romanholi LK, Lobo Recio MA. Aqueous and solid complexes of iron(III) with hyaluronic acid: potentiometric titrations and infrared spectroscopy studies. J Inorg Biochem. 2002;89:212–8.[Medline]
22. Kastenmayer P, Davidsson L, Galan P, Cherouvrier F, Hercberg S, Hurrell RF. A double stable-isotope technique for measuring iron-absorption in infants. Br J Nutr. 1994;71:411–24.[Medline]
23. Walczyk T, Davidsson L, Zavaleta N, Hurrell RF. Stable isotope labels as a tool to determine the iron absorption by Peruvian school children from a breakfast meal. Fresenius J Anal Chem. 1997;359:445–9.
24. Linseisen J, Kesse E, Slimani N, Bueno-De-Mesquita HB, Ocke MC, Skeie G, Kumle M, Dorronsoro Iraeta M, Morote Gomez P, et al. Meat consumption in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts: results from 24-hour dietary recalls. Public Health Nutr. 2002;5:1243–58.[Medline]
25. Fidler MC, Davidsson L, Zeder C, Hurrell RF. Erythorbic acid is a potent enhancer of nonheme-iron absorption. Am J Clin Nutr. 2004;79:99–102.
26. Sieck GC. Genome and hormones: an integrated approach to gender differences in physiology. J Appl Physiol. 2001;91:1485–6.
27. Hallberg L. Does calcium interfere with iron absorption? Am J Clin Nutr. 1998;68:3–4.[Medline]
28. Cook JD, Monsen ER. Vitamin C, the common cold, and iron absorption. Am J Clin Nutr. 1977;30:235–41.
29. Baech SB, Hansen M, Bukhave K, Jensen M, Sorensen SS, Kristensen L, Purslow PP, Skibsted LH, Sandstrom B. Nonheme-iron absorption from a phytate-rich meal is increased by the addition of small amounts of pork meat. Am J Clin Nutr. 2003;77:173–9.
30. MacPhail AP, Patel RC, Bothwell TH, Lamparelli RD. EDTA and the absorption of iron from food. Am J Clin Nutr. 1994;59:644–8.
31. Davidsson L, Walczyk T, Zavaleta N, Hurrell R. Improving iron absorption from a Peruvian school breakfast meal by adding ascorbic acid or Na2EDTA. Am J Clin Nutr. 2001;73:283–7.
32. Pearson AM, Young RB. Muscle and meat biochemistry. San Diego: Academic Press; 1989.
This article has been cited by other articles:
![]() |
C. N. Armah, P. Sharp, F. A. Mellon, S. Pariagh, E. K. Lund, J. R. Dainty, B. Teucher, and S. J. Fairweather-Tait L-{alpha}-Glycerophosphocholine Contributes to Meat's Enhancement of Nonheme Iron Absorption J. Nutr., May 1, 2008; 138(5): 873 - 877. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jin and R. P. Glahn Effect of Glycosaminoglycans on Nonheme Iron Absorption J. Nutr., October 1, 2007; 137(10): 2329 - 2329. [Full Text] [PDF] |
||||
![]() |
S. S. g. Bonsmann and R. Hurrell Reply to Jin and Glahn J. Nutr., October 1, 2007; 137(10): 2330 - 2330. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||